Repeat Dose Toxicity Clause Samples

The Repeat Dose Toxicity clause outlines the requirements and procedures for evaluating the effects of repeated exposure to a substance over a specified period. Typically, this involves conducting studies in which test subjects, such as laboratory animals, receive multiple doses of the substance to observe any cumulative or long-term toxic effects. The clause ensures that any potential health risks from repeated use are identified and assessed, thereby protecting human health and supporting regulatory compliance for product safety.
Repeat Dose Toxicity. Genotoxicity
Repeat Dose Toxicity. 1 [*][Exclusion of confidential technical information] 3 [*][Exclusion of confidential technical information] 3 [*][Exclusion of confidential technical information] 3 [*][Exclusion of confidential technical information] 3 [*][Exclusion of confidential technical information] 3 The following report is described in the report 4.2.3.2(5): [*][Exclusion of confidential technical information] 4 [*][Exclusion of confidential technical information] 4 [*][Exclusion of confidential technical information] 4 [*][Exclusion of confidential technical information] 4 [*][Exclusion of confidential technical information] 4 [*][Exclusion of confidential technical information]

Related to Repeat Dose Toxicity

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Substance Abuse Testing The Parties agree that it is in the best interest of all concerned to promote a safe working environment. The Union has no objection to pre-employment substance abuse testing when required by the Employer and further, the Union has no objection to voluntary substance abuse testing to qualify for employment on projects when required by a project owner. The cost and scheduling of such testing shall be paid for and arranged by the Employer. The Union agrees to reimburse the Employer for any failed pre-access Alcohol and Drug test costs.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act. (B) All classes covered by this Agreement are designated special risk classes for drug testing purposes. Special risk means employees who are required as a condition of employment to be certified under Chapter 633 or Chapter 943, F.S. (C) An employee shall have the right to grieve any disciplinary action taken under section 112.0455, the Drug-Free Workplace Act, subject to the limitations on the grievability of disciplinary actions in Article 10. If an employee is not disciplined but is denied a demotion, reassignment, or promotion as a result of a positive confirmed drug test, the employee shall have the right to grieve such action in accordance with Article 6.